Zacks Investment Research
29 Jul 2026, 16:46 UTC · 1d ago
GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
29 Jul 2026, 16:46 UTC · 1d ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
GE HealthCare reported Q2 2026 adjusted EPS of $1.13, beating the Zacks Consensus Estimate of $1.04 by 8.7%. — An earnings beat typically triggers immediate positive price action, as evidenced by the 8.3% pre-market jump.
+0.40GE HealthCare's total company orders increased 11.1% year-over-year organically, resulting in a record backlog of $23.9 billion. — A record backlog and rising book-to-bill ratio (1.15X) suggest strong future revenue visibility and demand.
+0.30Pharmaceutical Diagnostics and Advanced Imaging Solutions segments saw revenue growth of 15.6% and 7.9% respectively. — Strong performance in core high-margin segments supports the overall growth thesis for the company.
+0.20Continue reading
6 related stories
Top 1 mover · tap to explore
Patient Care Solutions revenues declined 13.3% year-over-year due to operational and fulfillment challenges. — Double-digit declines in a specific segment indicate internal operational headwinds that could drag on total growth.
-0.20Which stocks this story touches
The company beat EPS and revenue estimates, reported a record backlog, and saw shares rise 8.3% in pre-market trading.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
13h ago
